Sera from patients with scleroderma (systemic sclerosis [SSc]) contain anti–endothelial cell antibodies (AECAs) capable of inducing endothelial cell apoptosis. We sought to determine whether SSc sera containing anticentromere antibodies (ACAs) or anti–topoisomerase I antibodies (or, anti–Scl-70 antibodies) contain subsets of AECAs that trigger distinct pathways of apoptosis and gene expression in normal adult human dermal endothelial cells (HDECs).

Methods

Adult HDECs were grown to subconfluence and treated with control or SSc patient sera. Apoptosis was investigated by differential interference contrast (DIC) microscopy, microarrays of proapoptotic gene expression, caspase 3 protease activity, and flow cytometry for phosphatidyl serine translocation.

Results

Flow cytometry and DIC microscopy demonstrated that HDECs exposed to SSc sera containing either SSc autoantibody underwent apoptosis at much higher levels than those treated with control sera. While unique gene expression profiles were induced in HDECs by stimulation with SSc sera containing the respective autoantibody, similar patterns of increased gene expression of transcripts for the proapoptotic protease caspase 3 as well as the SSc autoantigen fibrillin 1 were demonstrated. Caspase 3 gene expression correlated with increased protease activity, and targeted inhibition of this protease partly blocked SSc serum–induced apoptosis. Immunohistochemistry studies of serum-stimulated HDECs demonstrated the aberrant expression of fibrillin 1 protein only in apoptotic endothelial cells treated with SSc sera containing AECAs.

Conclusion

There are distinct AECA subsets in the sera of patients with limited SSc (with ACAs) and diffuse SSc (with anti–Scl-70) that induce unique patterns of HDEC gene expression in the setting of apoptosis associated with increased caspase 3 activity and the reexpression of endothelial cell fibrillin 1.

REFERENCES

1 Medsger TA. Systemic sclerosis (scleroderma), localized forms of scleroderma, and calcinosis. In: DJ McCarty, WJ Koopman, editors. Arthritis and allied conditions: a textbook of rheumatology. 12th ed. Philadelphia: Lea & Febiger; 1993. p. 1253–99.
Google Scholar
2 Ahmed SS, Tan FK, Arnett FC. The complex genetics of scleroderma. Am J Med 2002; 112: 584–6.
10.1016/S0002-9343(02)01098-7
PubMed Web of Science® Google Scholar
3 Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996; 98: 785–92.
10.1172/JCI118851
CAS PubMed Web of Science® Google Scholar
4 Bordron A, Dueymes M, Levy Y, Jamin C, Leroy JP, Piette JC, et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998; 101: 2029–35.
10.1172/JCI2261
CAS PubMed Web of Science® Google Scholar
5 Kahaleh B. Immunologic aspects of scleroderma. Curr Opin Rheumatol 1993; 5: 760–5.
10.1097/00002281-199305060-00011
CAS PubMed Google Scholar
6 Blann AD, Illingworth K, Jayson MI. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993; 20: 1325–30.
CAS PubMed Web of Science® Google Scholar
7 Hu PQ, Fertig N, Medsger TA Jr, Wright TM. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 2003; 48: 1363–73.
10.1002/art.10977
CAS PubMed Web of Science® Google Scholar
8 Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ. Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 1992; 35: 688–93.
10.1002/art.1780350614
PubMed Web of Science® Google Scholar
9 Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994; 37: 75–83.
10.1002/art.1780370111
CAS PubMed Web of Science® Google Scholar
10 Schachna L, Wigley FM, Morris S, Gelber AC, Rosen A, Casciola-Rosen L. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss. Arthritis Rheum 2002; 46: 1873–84.
10.1002/art.10407
CAS PubMed Web of Science® Google Scholar
11 Hill M, Phipps JL, Cartwright R, Ward A, Greaves M, Hughes P. Antibodies to membranes of endothelial cells and fibroblasts in scleroderma. Clin Exp Immunol 1996; 106: 491–7.
10.1046/j.1365-2249.1996.d01-867.x
CAS PubMed Web of Science® Google Scholar
12 Kuwana M, Feghali CA, Medsger TA Jr, Wright TM. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis. Arthritis Rheum 2001; 44: 1654–9.
10.1002/1529-0131(200107)44:7<1654::AID-ART288>3.0.CO;2-O
CAS PubMed Web of Science® Google Scholar
13 McHugh NJ, Harvey GR, Whyte J, Dorsey JK. Segregation of autoantibodies with disease in monozygotic twin pairs discordant for systemic sclerosis. Three further cases. Arthritis Rheum 1995; 38: 1845–50.
10.1002/art.1780381219
CAS PubMed Web of Science® Google Scholar
14 Henault J, Tremblay M, Clement I, Raymond Y, Senecal JL. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 2004; 50: 3265–74.
10.1002/art.20515
CAS PubMed Web of Science® Google Scholar
15 Utz PJ, Gensler TJ, Anderson P. Death, autoantigen modifications, and tolerance. Arthritis Res 2000; 2: 101–14.
10.1186/ar75
CAS PubMed Web of Science® Google Scholar
16 Casciola-Rosen LA, Miller DK, Anhault GJ, Rosen A. Specific cleavage of the 70kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994; 269: 30757–60.
CAS PubMed Web of Science® Google Scholar
17 Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999; 190: 815–26.
10.1084/jem.190.6.815
CAS PubMed Web of Science® Google Scholar
18 Utz PJ, Hottelet M, Le TM, Kim SJ, Geiger ME, van Venrooij WJ, et al. The 72 kDa component of the signal recognition particle is cleaved during apoptosis. J Biol Chem 1998; 273: 35299–361.
10.1074/jbc.273.52.35362
PubMed Web of Science® Google Scholar
19 Tan FK, Arnett FC, Antohi S, Saito S, Mirarchi A, Spiera H, et al. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol 1999; 163: 1066–72.
CAS PubMed Web of Science® Google Scholar
20 Tan FK, Arnett FC, Reveille JD, Ahn C, Antohi S, Sasaki T, et al. Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles. Arthritis Rheum 2000; 43: 2464–71.
10.1002/1529-0131(200011)43:11<2464::AID-ANR13>3.0.CO;2-F
CAS PubMed Web of Science® Google Scholar
21 Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000; 6: 1183–6.
10.1038/80533
CAS PubMed Web of Science® Google Scholar
22 Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90.
10.1002/art.1780230510
PubMed Google Scholar
23 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7.
10.1002/art.1780251101
CAS PubMed Web of Science® Google Scholar
24 Carvalho D, Savage CO, Isenberg D, Person JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest 1996; 97: 111–9.
10.1172/JCI118377
CAS PubMed Web of Science® Google Scholar
25 Tan FK, Hildebrand BA, Lester MS, Stivers DN, Pounds S, Zhou X, et al. Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum 2005; 52: 865–76.
10.1002/art.20871
CAS PubMed Web of Science® Google Scholar
26 Yazici ZA, Raschi E, Patel A, Testoni C, Borghi MO, Graham AM, et al. Human monoclonal anti-endothelial IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro. Int Immunol 2001; 13: 329–57.
10.1093/intimm/13.3.349
PubMed Web of Science® Google Scholar
27 Papa ND, Raschi E, Moroni G, Panzeri P, Borghi MO, Ponticelli C, et al. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro. Lupus 1999; 8: 423–9.
10.1177/096120339900800603
CAS PubMed Web of Science® Google Scholar
28 Horvathova M, Jahnova E, Nyulassy S. Detection of antiendothelial cell antibodies in patients with connective tissue diseases by flow cytometry and their relation to endothelial cell activation. Physiol Res 2002; 51: 613–7.
CAS PubMed Web of Science® Google Scholar
29 Dieude M, Senecal JL, Raymond Y. Induction of endothelial cell apoptosis by heat-shock protein 60–reactive antibodies from anti–endothelial cell autoantibody–positive systemic lupus erythematosus patients. Arthritis Rheum 2004; 50: 3221–31.
10.1002/art.20564
CAS PubMed Web of Science® Google Scholar
30 Muller Kobold AC, van Wijk RT, Franssen CF, Molema G, Kallenberg CG, Tervaert JW. In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis. Clin Exp Rheumatol 1999; 17: 433–40.
CAS PubMed Web of Science® Google Scholar
31 Villa P, Kaufmann S, Earnshaw W. Caspases and caspase inhibitors. Trends Biochem Sci 1997; 22: 388–93.
10.1016/S0968-0004(97)01107-9
CAS PubMed Web of Science® Google Scholar
32 Tan FK, Stivers DN, Foster MW, Chakraborty R, Howard RF, Milewicz DM, et al. Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population. Arthritis Rheum 1998; 41: 1729–37.
10.1002/1529-0131(199810)41:10<1729::AID-ART5>3.0.CO;2-8
CAS PubMed Web of Science® Google Scholar
33 Kodera T, Tan FK, Sasaki T, Arnett FC, Bona CA. Association of 5′-untranslated region of the fibrillin-1 gene with Japanese scleroderma. Gene 2002; 297: 61–7.
10.1016/S0378-1119(02)00862-4
CAS PubMed Web of Science® Google Scholar
34 Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352: 337–9.
10.1038/352337a0
CAS PubMed Web of Science® Google Scholar
35 Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003; 33: 407–11.
10.1038/ng1116
CAS PubMed Web of Science® Google Scholar
36 Gerli R, Agliano M. Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics. Lymphology 2000; 33: 148–57.
CAS PubMed Web of Science® Google Scholar
37 Wu XX, Rand JH. Morphological relationships of von Willebrand factor, type VI collagen, and fibrillin in human vascular subendothelium. Am J Pathol 1996; 149: 283–91.
CAS PubMed Web of Science® Google Scholar
38 Davis EC. Immunolocalization of microfibril and microfibril-associated proteins in the subendothelial matrix of the developing mouse aorta. J Cell Science 1994; 107: 727–36.
CAS PubMed Web of Science® Google Scholar
39 Makhluf HA, Stepniakowska J, Hoffman S, Smith E, LeRoy EC, Trojanowska M. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. J Invest Dermatol 1996; 107: 856–9.
10.1111/1523-1747.ep12331160
CAS PubMed Web of Science® Google Scholar
40 Zhou X, Tan FK, Milewicz DM, Guo X, Bona C, Arnett FC. Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-β pathway to recapitulate the “scleroderma phenotype”. J Immunol 2005; 175: 4555–60.
10.4049/jimmunol.175.7.4555
CAS PubMed Web of Science® Google Scholar
41 Worda M, Sgonc R, Dietrich H, Niederegger H, Sundick RS, Gershwin ME, et al. In vivo analysis of the apoptosis-inducing effect of anti–endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum 2003; 48: 2605–14.
10.1002/art.11179
CAS PubMed Web of Science® Google Scholar
42 Sgonc R, Gruschwitz MS, Boeck G, Norbert S, Gruber J, Wick G. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 2000; 43: 2550–62.
10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H
CAS PubMed Web of Science® Google Scholar
43 Renaudineau Y, Grunebaum E, Krause I, Praprotnik S, Revelen R, Youinou P, et al. Anti-endothelial cell antibodies (AECA) in systemic sclerosis: increased sensitivity using different endothelial cell substrates and association with other autoantibodies. Autoimmunity 2001; 33: 171–9.
10.3109/08916930109008045
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume54, Issue7

July 2006

Pages 2250-2262

Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti–endothelial cell antibodies

Abstract

Objective

Methods

Results

Conclusion

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti–endothelial cell antibodies

Abstract

Objective

Methods

Results

Conclusion

REFERENCES

Citing Literature

References

Related

Information